Glycom A/S clinical trials
Acquired by dsm-firmenich, Apr 17, 2023 · source ↗
The registry lists 4 studies whose lead sponsor is Glycom A/S. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 25, 2019.
Before and after it joined dsm-firmenich
- First submitted before Glycom A/S became part of dsm-firmenich
- 4
- First submitted after Glycom A/S became part of dsm-firmenich
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Glycom A/S3 studies
- Glycom, Inc.1 study
Something wrong with this grouping? Tell us on the dsm-firmenich page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All dsm-firmenich studies →
- Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS PatientsCompletedNCT03550742Not applicable
Sponsor listed in the registry: Glycom, Inc. · First submitted before Glycom, Inc. became part of dsm-firmenich
- Effects of HMOs on the Faecal Microbiota and on Host Metabolism in Obese ChildrenCompletedNCT02786160Not applicable
Sponsor listed in the registry: Glycom A/S · First submitted before Glycom A/S became part of dsm-firmenich
- Effects of HMOs on Faecal Microbiota, Gastrointestinal Symptoms, Mucosal Immunity and Barrier Function in IBS PatientsCompletedNCT02875847Phase 2
Sponsor listed in the registry: Glycom A/S · First submitted before Glycom A/S became part of dsm-firmenich
- The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy VolunteersCompletedNCT01927900Not applicable
Sponsor listed in the registry: Glycom A/S · First submitted before Glycom A/S became part of dsm-firmenich